Search
3 articles for “Natural Killer (NK) cells”
-
Beyond Chemotherapy: The Promise of Immunotherapy in Cancer Care and Advancements in Cancer Therapy
Abstract: Recent advances in cancer immunotherapy harness the immune system to precisely target cancer. These include the use of immunosuppressive agents, NK cell recovery, changes in tumor microenvironment metabolic, and aging to achieve a positive tumor response The article explores how the body development of the immune system in the late 19th century, highlighting milestones such as the discovery and FDA approval of IL2. Different categories of immunology are explored, from …
Published in Research and Reviews : A Journal of Immunology · Vol. 13, Issue 2, 2023 · pp. 22–37 Read article
-
Hematopoietic Stem Cells: Sources and Therapeutic Potential for Autoimmune Diseases and Cancer
Abstract: Hematopoietic stem cells (HSCs) are a group of multipotent adult stem cells that are responsible for lifelong production of all types of functional blood cells comprising myeloid (monocytes, macrophages, granulocytes), megakaryocytes/platelets, red blood cells (erythrocyte), T-cells, B-cells, natural killer (NK) cells, mast cells and dendritic cells (DCs). HSCs have the capacity for self-renewal and differentiation into various tissues. These remarkable properties of HSCs make them an ideal tool for tissue …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 1, Issue 3, 2012 · pp. 6–14 Read article
-
Extranodal NK/T-Cell Lymphoma; Dilemma in Diagnosis and Management: A Review of Literature
Abstract: Natural killer (NK) cell neoplasms are rare malignancies. They are classified as extranodal NK-cell lymphoma, nasal type, and aggressive NK-cell leukaemia. Clinically they can be classified as nasal type, non-nasal type, and aggressive lymphoma/leukaemia. Stage I/II Nasal NK-cell lymphoma are treated by combined chemotherapy and radiotherapy. In case of stage III/IV nasal NK-cell lymphoma, as well as non-nasal and aggressive lymphomas/leukaemias, chemotherapy is the main treatment. In selected cases, allogenic …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 3, Issue 3, 2014 · pp. 4–12 Read article